XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Revenues $ 2,259 $ 2,153
Expenses    
Selling, general and administrative 867 794
Research and development 143 151
Amortization of intangible assets 256 274
Asset impairments 0 1
Restructuring, integration and separation costs 1 12
Other expense, net 15 0
Total expenses 1,983 1,872
Operating income 276 281
Interest income 11 9
Interest expense (330) (355)
Gain on extinguishment of debt 0 11
Foreign exchange and other (4) (15)
Loss before income taxes (47) (69)
Provision for income taxes (39) (8)
Net loss (86) (77)
Net loss attributable to noncontrolling interest 28 13
Net loss attributable to Bausch Health Companies Inc. $ (58) $ (64)
Basic loss per share attributable to Bausch Health Companies Inc. (in dollars per share) $ (0.16) $ (0.17)
Diluted loss per share attributable to Bausch Health Companies Inc. (in dollars per share) $ (0.16) $ (0.17)
Basic weighted-average common shares (in shares) 369.6 366.8
Diluted weighted-average common shares (in shares) 369.6 366.8
Product sales    
Revenues    
Revenues $ 2,227 $ 2,129
Expenses    
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 683 628
Other revenues    
Revenues    
Revenues 32 24
Expenses    
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 18 $ 12